{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03611582","recordId":"NCT03611582","peptideSlug":"semaglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03611582-semaglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03611582.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03611582.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-08-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-08-01","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"2c7931ae740adad60117929914986281b6d143dcda3338f6d6986834efea720c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-08-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-08-03","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"7376dd5b9fc11300abb930d35b413b90509eb58287c73ee736f85b9c18384a03","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-08-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-08-08","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"091ed3d835e58047f80e9694b1e5b41d32697aa5aac759edc1899f1ec98f697f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-08-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-08-10","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"512d6ac92ebb02482e58359ed5ef94f8f2e10164aaa2d5d7522ed762e27397f9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2018-08-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-08-13","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"2f600d80615fbb013aafe916f09936ff584ce3d82e1003b140a37b12fa69ea86","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2018-08-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-08-15","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"02106aaae09476e991b700dca3d07a2175ca905e57ec3cc1b8d5dc805f3762ad","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2018-08-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-08-17","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"94c3e5cadeb3ea75036a3ede43802f92e3b94bf165bd21be1ae622348ed97589","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2018-09-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-09-03","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"934f9d2db1d35d866eb325f28b2fd62fe277f434230821455f10f7e89cf22302","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2018-09-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-09-12","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"ee82fc0865c72585aa32ef024da29990aed11ecf43eb34d3928900f7f23a17fa","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2018-09-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-09-21","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"251d829d78a25d780a0f31ffc2447ad310b43a8dbf6a303d958e86cce0ba2f16","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2018-10-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-10-04","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"fd05a95afb9127a1b7205e0256abba0dde90b3bc94fa6085c8161ec872d9354b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2018-11-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-11-28","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"dc64fde4cd22b583bddfd351d39bc8b1aabf8de12bcf2377a1fcfc230e26c2e4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2018-11-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-11-29","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"2eb0e83c18cbe7d725bb548a7a7626e38bdc6be82472d70964587f8476cf3a50","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2018-11-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2018-11-30","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"600a9a744fa781ae9c5657b2b1d9a80bdbf8cba5d7793f7c3a0f39cdd8283689","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2019-05-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2019-05-09","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"b95733097f53d9f53120614feb17296eaf2f3b44b2972593224c837b59c47618","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Outcome Measures","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2019-05-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2019-05-29","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"f8ed6d2b0960d3feee136570ba7b794d06ce5cd17313507cd9e8491978533c03","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2020-03-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2020-03-24","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"afbe48225eba36ee3786716ad71ff938f11ba89da51fa692937af45a2c209b75","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2020-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2020-04-01","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"b5eef45d2181d791613cc1f9ecea4f552709038fc93ee6af979682331235ac90","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2020-04-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2020-04-20","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"a8553dff2ec0cc0a563e08d74a5501e0f94592a0f7bbde179c020af530458548","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2020-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2020-04-27","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"8c5e83fee34989072d56708e5c2879058a1c63af776ff46d580531d95c07574c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2020-04-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"semaglutide","submittedDate":"2020-04-30","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"6993b80f1cd7b0f10166ef7749047e9ef5db0e18f6260c697c44a9471d8399c1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2020-05-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"semaglutide","submittedDate":"2020-05-06","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"4cc7bfb8936705da0d620512ae777fab7a7a62765a3db181e6dbfb0508a5c269","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2020-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"semaglutide","submittedDate":"2020-05-13","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"7e7c3549dda68f2aecbed5162213a4243bad5fbe6be113888117a48f8fd7f28f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2020-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"semaglutide","submittedDate":"2020-05-19","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"55e3f46b35de6cf3207768aa9481797d3c0454dcfe7fe8951519e8889335fcf5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2020-06-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"semaglutide","submittedDate":"2020-06-02","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"7e7017c1723b6f37dd68441501f2438b42a6b40e097dbd4437710e4713b67271","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2021-03-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"semaglutide","submittedDate":"2021-03-03","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"0cb1e179ad4e869e4955dc8cd1c88603341fb54bdde81609faf86d8b724e4631","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2021-03-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"semaglutide","submittedDate":"2021-03-10","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"f21fb7d0a97a3823586071913344ca6c7e33a8dbe3ec4b01c7ea4f6bdbe84330","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Contacts/Locations","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2021-06-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"semaglutide","submittedDate":"2021-06-16","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"ddf1e1fd21bb8b56396597bb3c0ad362cb414207c56fb14306486eaee856d2b8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=28&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":29,"lastUpdateSubmitQcDate":"2021-11-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"semaglutide","submittedDate":"2021-11-10","publishedAt":"2026-08-23","recordId":"NCT03611582","recordSha256":"17feb3013877ef4ffff446695bfca872acf8a09b38fca08f8e89ccc4d3ab303c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03611582?a=29&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"fb23ada765c983953c787635bed802fe126e4fc00da220d7499071ba7ce2f2d6"}}